| scholarly article | Q13442814 |
| P50 | author | Bradley M Haverkos | Q87988147 |
| P2093 | author name string | Rosemary Rochford | |
| Roberta Pelanda | |||
| Brian M Freed | |||
| Nicholas A Smith | |||
| Zenggang Pan | |||
| Julie Lang | |||
| Carrie B Coleman | |||
| Lydia A Sweet | |||
| P2860 | cites work | Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data | Q24605194 |
| Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States | Q24617384 | ||
| Priming of protective T cell responses against virus-induced tumors in mice with human immune system components | Q24645297 | ||
| Humanized hemato-lymphoid system mice | Q26771440 | ||
| PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model | Q27313748 | ||
| Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice | Q27324235 | ||
| Increased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell Lymphoma | Q30276132 | ||
| The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment | Q30278553 | ||
| CD34+ cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infection | Q33374980 | ||
| A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice | Q33394809 | ||
| Current advances in humanized mouse models | Q33577361 | ||
| Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells | Q33929593 | ||
| Epstein-Barr virus induces erosive arthritis in humanized mice | Q34058760 | ||
| A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas | Q34457976 | ||
| The role of Epstein-Barr virus in cancer | Q34574840 | ||
| Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection | Q35017882 | ||
| Modeling EBV infection and pathogenesis in new-generation humanized mice | Q35040650 | ||
| Generation of hematopoietic humanized mice in the newborn BALB/c-Rag2null Il2rγnull mouse model: a multivariable optimization approach | Q35046300 | ||
| Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines. | Q35115666 | ||
| Functional CD47/signal regulatory protein alpha (SIRP(alpha)) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo | Q35164726 | ||
| Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations | Q35232848 | ||
| LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis | Q35242466 | ||
| Epstein-Barr virus genetic variation in lymphoblastoid cell lines derived from Kenyan pediatric population | Q35620244 | ||
| Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection | Q35641421 | ||
| EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors | Q35858022 | ||
| An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model | Q36171933 | ||
| Advances in human B cell phenotypic profiling | Q36307080 | ||
| Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturation | Q36626153 | ||
| Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts | Q36696963 | ||
| Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. | Q36766875 | ||
| Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. | Q36781303 | ||
| Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes | Q36782491 | ||
| Functional and phenotypic characterization of the humanized BLT mouse model | Q37164275 | ||
| Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection | Q37493561 | ||
| The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal | Q37549340 | ||
| Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site | Q37552683 | ||
| U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2 | Q37579511 | ||
| Humanized Mouse Models of Clinical Disease | Q37614202 | ||
| Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes | Q37849461 | ||
| Plasmablastic lymphoma and related disorders | Q37901233 | ||
| The pathogenesis of Epstein-Barr virus persistent infection. | Q38107595 | ||
| Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders | Q38179491 | ||
| T cells modulate Epstein-Barr virus latency phenotypes during infection of humanized mice | Q38326876 | ||
| Humanized mouse models for Epstein Barr virus infection | Q38637726 | ||
| Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression. | Q38680794 | ||
| Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences | Q38808086 | ||
| Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes. | Q39868327 | ||
| One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection | Q40080132 | ||
| Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells | Q40132148 | ||
| Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma | Q40236746 | ||
| Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential. | Q40375799 | ||
| The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell | Q40843575 | ||
| Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma | Q41131431 | ||
| CD5 expression is regulated during human T-cell activation by alternative polyadenylation, PTBP1, and miR-204 | Q41377606 | ||
| Epstein-Barr Virus Type 2 Infects T Cells in Healthy Kenyan Children | Q41932818 | ||
| New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas | Q42817224 | ||
| A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses | Q43939988 | ||
| Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders | Q44168712 | ||
| Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus | Q44570865 | ||
| Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease | Q44983123 | ||
| Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children | Q45407247 | ||
| The genome of Epstein-Barr virus type 2 strain AG876. | Q45419603 | ||
| Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children | Q45496126 | ||
| Distribution and localization of Epstein-Barr virus subtypes A and B in AIDS-related lymphomas and lymphatic tissue of HIV-positive patients | Q45876229 | ||
| Current research on chronic active Epstein-Barr virus infection in Japan. | Q51849571 | ||
| Interleukin-6 is a growth factor for nonmalignant human plasmablasts. | Q52021179 | ||
| Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. | Q53592113 | ||
| Epstein-Barr virus-associated lymphomas | Q56930876 | ||
| Essential role for T cells in human B-cell lymphoproliferative disease development in severe combined immunodeficient mice | Q73968462 | ||
| Replacing mouse BAFF with human BAFF does not improve B-cell maturation in hematopoietic humanized mice | Q89777737 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| immunology | Q101929 | ||
| P304 | page(s) | JVI.00813-18 | |
| P577 | publication date | 2018-11-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice | |
| P478 | volume | 92 |
| Q89717789 | B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection |
| Q91709780 | Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity |
| Q58616776 | PD-1 immunobiology in systemic lupus erythematosus |
| Q92008485 | T Lymphocyte Development and Activation in Humanized Mouse Model |
| Q92860015 | The Global Landscape of EBV-Associated Tumors |
Search more.